SBIO.AS Invesco NASDAQ Biotech UCITS ETF

ETF Healthcare Equity Invesco Investment Management Limited Euronext Amsterdam
68.11 EUR
Close of Oct 29, 2026
47.01 68.11
Total assets
276M
Expense ratio
0.41%
Dividend yield
0.85%
1-year return
+36.39%
Holdings
1
Since
2014

Fund data as reported by the issuer, updated Oct 28, 2026. Total assets are in the fund's base currency.

What does SBIO.AS invest in?

Tracks Morningstar Gbl Biotechnology NR USD
  • Mostly US stocks (97.4%)
  • Largest sector: Healthcare (100.0%)
  • Largest region: North America (91.9%)

Asset allocation

  • US stocks 97.4%
  • Non-US stocks 4.7%

Invesco NASDAQ Biotech UCITS ETF performance

Sharpe ratio 1.03
This year
+23.85%
1 year
+36.39%
3 years
+25.23%
5 years
+8.17%

Volatility 17.1% over 1 year and 17.6% over 3 years. Moderate, similar to a broad stock index.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

SBIO.AS price

Prices on the chart can differ slightly from the closing prices StockSummer shows.